New: Introducing the Finviz Crypto Map

Learn More

Compared to Estimates, Altria (MO) Q2 Earnings: A Look at Key Metrics

By Zacks Equity Research | July 30, 2025, 9:30 AM

For the quarter ended June 2025, Altria (MO) reported revenue of $5.29 billion, up 0.3% over the same period last year. EPS came in at $1.44, compared to $1.31 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $5.19 billion, representing a surprise of +1.93%. The company delivered an EPS surprise of +5.11%, with the consensus EPS estimate being $1.37.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Altria performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Revenues net of excise taxes- Smokeable Products: $4.57 billion versus $4.43 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -0.4% change.
  • Net revenue- All Other/ Financial Services: $-8 million versus the three-analyst average estimate of $14 million. The reported number represents a year-over-year change of -366.7%.
  • Revenues net of excise taxes- Oral tobacco products: $728 million versus $701.72 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6% change.
  • Adjusted OCI- Smokeable Products: $2.95 billion compared to the $2.86 billion average estimate based on three analysts.
  • Operating Income (Loss)/ Reported OCI- All Other/ Financial Services: $-108 million versus the three-analyst average estimate of $-108.5 million.
  • Operating Income (Loss)/ Reported OCI- Oral tobacco products: $498 million versus the three-analyst average estimate of $459.6 million.

View all Key Company Metrics for Altria here>>>

Shares of Altria have returned +2.1% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Altria Group, Inc. (MO): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Latest News